Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
197.50    0.00 (0.00%)
Bid:
195.00
Ask:
200.00
Spread: 5.00 (2.564%)
Market Cap: £114.69m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

Director's Dealings

23 Nov 2017 10:21

RNS Number : 3533X
Focusrite PLC
23 November 2017
 

Focusrite Plc

 

("the Company" or "the Group")

 

Directors' Dealings

Grant of Share Options to Directors

 

Focusrite Plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 22 November 2017 it issued 126,240 options under the Company's Performance Share Plan to Tim Carroll, CEO of the Company and Jeremy Wilson, CFO of the Company as listed below. The awards have a vesting date of 22 November 2020.

 

Director

Options granted

Tim Carroll

70,176

Jeremy Wilson

56,064

 

The performance measurement period is from 1 September 2017 to 31 August 2020 and the awards will vest subject to the rules of the Focusrite Plc Performance Share Plan and the Remuneration Committee's determination of the extent to which the performance conditions applicable to the award have been satisfied. Full details of these performance conditions are set out in the Company's Directors' Remuneration Report for the year ending 31 August 2017. Vested awards are exercisable until the tenth anniversary of the grant date, subject to the individual's ongoing employment.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

1. Tim Carroll

3. Jeremy Wilson

2

Reason for the notification

a)

Position/status

 Directors of the Company

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite Plc

b)

LEI

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Option over Ordinary Shares of 0.1p each

Identification code

GB00BSBMW716

b)

Nature of the transaction

Grant of options pursuant to the Focusrite Plc Performance Share Plan

c)

Price(s) and volume(s)

 

Exercise Prices per share

Volumes

1. 0.1p

2. 0.1p

1. 70,176

2. 56,064

 

d)

Aggregated information

- Aggregated volume 

- Price 

Weighted average exercise price: 0.1p per share

Aggregated volume: 126,240

e)

Date of the transaction

22 November 2017

f)

Place of the transaction

Outside a trading venue

 

 

-ends-

 

 

Enquiries:

 

Focusrite Plc:

 

Phil Dudderidge (Executive Chairman)

+44 1494 462246

Jeremy Wilson (CFO)

+44 1494 462246

 

 

Panmure Gordon

 

Freddy Crossley

+44 20 7886 2968

Tom Salvesen

+44 20 7886 2904

 

 

Belvedere Communications

 

John West

+44 20 3567 0510

Kim van Beeck

+44 20 3567 0510

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKNDDKBDDFDB
Date   Source Headline
27th May 20267:00 amRNSNotice of Results
5th May 20264:25 pmRNSTR-1
8th Apr 20263:56 pmRNSTR-1
19th Mar 20267:00 amRNSTrading Update: Trading in-line with expectations
2nd Mar 20267:00 amRNSBoard Changes
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:19 amRNSTransfer of shares to Trust
24th Dec 20259:19 amRNSTransfer of shares to Trust
18th Nov 202512:38 pmRNSDirector Share Dealings
4th Nov 20257:00 amRNSInterim Results
14th Oct 20257:00 amRNSNotice of Results
16th Sep 20257:00 amRNSTrading Update
7th May 20253:25 pmRNSTR-1
30th Apr 20253:41 pmRNSDividend Timetable Correction
29th Apr 20257:00 amRNSInterim Results
16th Apr 20252:38 pmRNSGrant of Share Options to PDMRs
11th Apr 20258:50 amRNSTR-1
8th Apr 20251:43 pmRNSTR-1
8th Apr 20257:00 amRNSTR-1
8th Apr 20257:00 amRNSTR-1
3rd Apr 20257:00 amRNSNotice of Interim Results
26th Mar 20253:16 pmRNSTR-1
20th Mar 20257:00 amRNSTrading Update
19th Mar 20258:13 amRNSTR-1
4th Mar 20252:46 pmRNSTR-1
31st Jan 202512:29 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement and Trading Update
11th Dec 20247:00 amRNSTR-1
5th Dec 20243:38 pmRNSDirector Share Dealings
5th Dec 20243:37 pmRNSGrant of Share Options to PDMRs
5th Dec 20247:00 amRNSTR1
27th Nov 20247:00 amRNSFinal Results for the Year Ended 31 Aug 2024
30th Oct 20247:00 amRNSNotice: Final Results, Change of Year End, Auditor
28th Aug 20247:00 amRNSTrading Statement
1st Aug 20247:00 amRNSTR-1
15th Jul 20244:17 pmRNSTR-1
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions
7th Feb 20242:25 pmRNSTR-1
19th Jan 202412:59 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.